Published in Immunogenetics on January 01, 1982
Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84
Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. Clin Exp Immunol (1986) 1.70
Origin of lymph node-derived lymphocytes in human hepatic allografts. Clin Transpl (1989) 1.24
Molecular localization of human class II MT2 and MT3 determinants. J Exp Med (1984) 1.05
Two-dimensional gel electrophoretic analysis of the MT3 and DR4 molecules from the different D-typed cells. J Exp Med (1984) 0.90
Defective antigen presentation and novel structural properties of DR1 from an HLA haplotype associated with 21-hydroxylase deficiency. J Clin Invest (1987) 0.78
Primed lymphocyte testing specificity of alloreactive lymphocyte clones for HLA-B locus determinants. Proc Natl Acad Sci U S A (1983) 0.78
Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54
Baboon-to-human liver transplantation. Lancet (1993) 4.01
Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Renal transplantation in baboons under FK 506. Surgery (1989) 3.17
Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13
A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet (1990) 2.89
Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84
Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients. Transplantation (1986) 2.82
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant (2013) 2.45
Clonal dominance among T-lymphocyte infiltrates in arthritis. Proc Natl Acad Sci U S A (1988) 2.36
Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant (2015) 2.24
A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant (2010) 2.14
Specificity of alloactivated human T lymphocyte clones in secondary proliferation, cell-mediated lympholysis and interleukin-2 release. J Immunogenet (1985) 1.82
Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients. Hum Immunol (1985) 1.65
Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation (1988) 1.61
Weaning of immunosuppression in long-term liver transplant recipients. Transplantation (1995) 1.59
Stimulation and inhibition of human T-lymphocyte colony cell proliferation by hemopoietic cell factors. Cell Immunol (1977) 1.58
Identification of an HLA-DR-associated system of B-cell alloantigens. Transplant Proc (1979) 1.57
FK-506 enhances cyclosporine uptake by peripheral blood lymphocytes. Transplant Proc (1987) 1.56
Large airway inflammation in heart-lung transplant recipients--its significance and prognostic implications. Transplantation (1990) 1.51
Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J Thorac Cardiovasc Surg (1995) 1.48
Multivisceral intestinal transplantation: surgical pathology. Pediatr Pathol (1989) 1.45
Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol (1997) 1.41
Ciprofloxacin does not block the antiproliferative effect of tacrolimus. Transplantation (1997) 1.39
Collins' sign: validation of a clinical sign in cholelithiasis. Ir J Med Sci (2009) 1.38
FK 506 as a growth control factor. Transplant Proc (1990) 1.36
Contribution of naïve and memory T-cell populations to the human alloimmune response. Am J Transplant (2009) 1.34
Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5. J Immunol (1982) 1.34
Sensitivity of activated human lymphocytes to cyclosporine and its metabolites. Hum Immunol (1988) 1.31
Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients. Transplant Proc (1994) 1.29
Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. Ther Drug Monit (1995) 1.28
Excretion of cyclosporine and its metabolites in human bile. Transplant Proc (1986) 1.27
Alloreactive T-cell recognition of two DQ beta allelic specificities associated with DQw1. Hum Immunol (1987) 1.26
Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells. Transplant Proc (1995) 1.24
Heart-lung transplantation: lessons learned and future hopes. Ann Thorac Surg (1987) 1.23
Dynamics of allospecific T lymphocyte infiltration in vascularized human allografts. Immunol Res (1986) 1.20
Serological and cellular definition of a new HLA-DR associated determinant, MC1, and its association with rheumatoid arthritis. Hum Immunol (1984) 1.19
Combined kidney/bone marrow transplantation--evidence of augmentation of chimerism. Transplantation (1995) 1.19
Practical aspects of FK 506 analysis (Pittsburgh experience). Transplant Proc (1991) 1.19
FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. Transplant Proc (1991) 1.15
Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation (1991) 1.13
Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506. Hepatology (1991) 1.13
Expression of HLA-B12, HLA-B8, w4, and w5 on platetelets. Transplant Proc (1977) 1.10
Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function. Transplantation (1995) 1.10
Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506. Transplantation (1991) 1.10
Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line. J Exp Med (1983) 1.10
Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation. Am J Transplant (2008) 1.10
HLA-DR associations in black type I diabetics in Nigeria. Further support for models of inheritance. Diabetes (1986) 1.08
Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression. Transplant Proc (1990) 1.08
Frequent achievement of a drug-free state after orthotopic liver transplantation. Transplant Proc (1993) 1.08
IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients. Clin Pharmacol Ther (2007) 1.07
T-lymphocyte colony growth in vitro: factors modulating clonal expansion. Immunol Rev (1981) 1.07
Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up. Transplant Proc (1997) 1.07
Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations. Arthritis Rheum (1992) 1.07
Population studies of the HLA-linked SB antigens. Immunogenetics (1981) 1.06
Association of HLA-DRw2 antigen with presumed ocular histoplasmosis. Am J Ophthalmol (1980) 1.05
Long-term culture of viable human pancreatic islets in pyruvate-rich medium. Transplant Proc (1995) 1.04
Immunological studies of the Snell-Bagg pituitary dwarf mouse. Proc Soc Exp Biol Med (1970) 1.04
Voriconazole prophylaxis in lung transplant recipients. Am J Transplant (2006) 1.04
Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. J Heart Lung Transplant (1992) 1.02
Combined bone marrow and whole organ transplantation from the same donor. Transplant Proc (1994) 1.02
Platelet migration inhibition: a new method for detection of platelet antibodies. Blood (1975) 1.01
Physicochemical characterization of six monoclonal cryoimmunoglobulins: possible basis for cold-dependent insolubility. Proc Natl Acad Sci U S A (1978) 1.00
16th IHIW: a website for antibody-defined HLA epitope Registry. Int J Immunogenet (2012) 1.00
C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody. Transpl Immunol (2005) 1.00
Upregulation of messenger RNA for inflammatory cytokines in middle ear mucosa in a rat model of acute otitis media. Ann Otol Rhinol Laryngol (1998) 1.00
Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. Transplant Proc (1996) 1.00
Analysis of T lymphocytes infiltrating human hepatic allografts. Transplant Proc (1987) 1.00
Increased lymphocyte adherence to human arterial endothelial cell monolayers in the context of allorecognition. J Immunol (1990) 1.00
Forward and reverse selection for longevity in Drosophila is characterized by alteration of antioxidant gene expression and oxidative damage patterns. Exp Gerontol (2000) 1.00
Immunologically mediated disease of the airways after pulmonary transplantation. Ann Surg (1988) 1.00
Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study. Transplant Proc (1995) 0.99
Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients. Ann Thorac Surg (1995) 0.98
Combined simultaneous kidney/bone marrow transplantation. Transplantation (1995) 0.98
Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up. Am J Transplant (2008) 0.98
Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation. Transplantation (1989) 0.98
Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver. Am J Transplant (2012) 0.97
Propagation and characterization of lymphocytes from transplant biopsies. Crit Rev Immunol (1991) 0.97
Thymus adenylate cyclase activity during murine leukemogenesis. Science (1974) 0.97
Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology (1991) 0.96